Are There Any Emerging Therapies Targeting Fusion Proteins?
Emerging therapies targeting fusion proteins include the development of bi-specific T-cell engagers (BiTEs) and chimeric antigen receptor (CAR) T-cell therapy. These innovative approaches aim to harness the immune system to specifically target and destroy cancer cells expressing fusion proteins. Additionally, advancements in RNA interference and CRISPR-Cas9 gene editing technologies hold promise for directly targeting the genetic abnormalities that give rise to fusion proteins.
